Kaposiform lymphangiomatosis effectively treated with MEK inhibitionJessica Foster, Yoav Dori, Dong Li et al.|EMBO Molecular Medicine|2020Cited by 104
Pathogenic variant in EPHB4 results in central conducting lymphatic anomalyDong Li, Håkon Håkonarson, Cuiping Hou et al.|Human Molecular Genetics|2018Cited by 100
Genomic profiling informs diagnoses and treatment in vascular anomaliesDong Li, Håkon Håkonarson, Sarah E. Sheppard et al.|Nature Medicine|2023Cited by 63
Treatment of severe Kaposiform lymphangiomatosis positive for NRAS mutation by MEK inhibitionGuy Chowers, Adi Dagan, Gadi Abebe‐Campino et al.|Pediatric Research|2022Cited by 51
Lymphatic disorders caused by mosaic, activating KRAS variants respond to MEK inhibitionSarah E. Sheppard, Håkon Håkonarson, Michael March et al.|JCI Insight|2023Cited by 37